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Introduction
The mechanisms driving skeletal muscle atrophy and dysfunction with ageing have been the subject of  intense 
study. A number of  factors have been suggested, including physical inactivity (1) and more intrinsic factors of  
ageing, such as epigenetic changes (2), oxidative stress (3), inflammation (4), DNA damage, and mitochon-
drial dysfunction (5, 6). However, one known major driver of  age-related muscle atrophy is so-called anabolic 
resistance (7, 8). This describes the phenomena whereby the main signals that maintain muscle mass and 
metabolic homeostasis, irrespective of  age, namely nutrition (9, 10) and physical activity (8, 11–13), become 
dysregulated. Specifically, when comparing the acute anabolic responses to feeding and exercise in younger 
versus older individuals, responses are lesser in the old. On a day-to-day and chronic basis, “anabolic resis-
tance” has therefore been suggested as a potential driver of  sarcopenia.
Resistance exercise training (RE-T) arguably remains the most potent nonpharmacological anabolic stim-
ulus for skeletal muscle and has been shown to enhance muscle mass and function in healthy younger (14), 
aged (15), and cachectic populations (16). Nonetheless, when looking at comparative gains in muscle mass 
following an allied program of supervised RE-T, muscle hypertrophic responses are typically blunted in older 
versus younger individuals. While the mechanisms for this remain incompletely defined, this is at least in part 
as a result of  impaired ribosomal biogenesis and long-term muscle protein synthesis (MPS) (8, 17, 18). Indeed, 
a meta-analysis on this topic showed that the gains in lean mass at an older age are modest (~1 kg) compared 
with what is observed at younger age (19). The age at which this diminution in the capacity for muscle hypertro-
phy manifests remains undefined. Moreover, whether such anabolic resistance is only a feature of  sarcopenia 
BACKGROUND. The impact of resistance exercise training (RE-T) across the life span is poorly 
defined.
METHODS. To resolve this, we recruited three distinct age cohorts of young (18–28 years; n = 11), 
middle-aged (45–55 years; n = 20), and older (nonsarcopenic; 65–75 years; n = 17) individuals to a 
cross-sectional intervention study. All subjects participated in 20 weeks of fully supervised whole-
body progressive RE-T, undergoing assessment of body composition, muscle and vascular function, 
and metabolic health biomarkers before and after RE-T. Individuals also received stable isotope 
tracer infusions to ascertain muscle protein synthesis (MPS).
RESULTS. There was an age-related increase in adiposity, but only young and middle-age groups 
demonstrated reductions following RE-T. Increases in blood pressure with age were attenuated 
by RE-T in middle-aged, but not older, individuals, while age-related increases in leg vascular 
conductance were unaffected by RE-T. The index of insulin sensitivity was reduced by RE-T in 
older age. Despite being matched at baseline, only younger individuals increased muscle mass 
in response to RE-T, and there existed a negative correlation between age and muscle growth; in 
contrast, increases in mechanical quality were preserved across ages. Acute increases in MPS (upon 
feeding plus acute RE-T) were enhanced only in younger individuals, perhaps explaining greater 
hypertrophy.
CONCLUSION. Our data indicate that RE-T offsets some, but not all, negative characteristics of 
ageing — some of which are apparent in midlife.
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or is also present in healthy older 
people with normal muscle mass 
is not known.
Ageing is also associated 
with a host of  other deleterious 
changes in body composition 
and metabolic health biomark-
ers. For instance, along with 
declines in lean mass, ageing 
is associated with increased 
adiposity (20), declines in bone 
mineral density (BMD) (21), 
reductions in insulin sensitivity 
(22), and reductions in vascular 
function (23) (e.g., endothelial 
function/arterial stiffness and 
increased blood pressure [BP]). 
Crucially, many of  these facets 
have been shown to be modi-
fiable by RE-T. For example, 
RE-T has been shown to reduce 
adiposity (24), lower BP (25), improve insulin sensitivity (26), and enhance BMD (27). Nonetheless, many 
of  the studies showing these benefits have been conducted either in healthy groups of  individuals (in spe-
cific age groups) or in relation to ameliorating the negative effects of  metabolic diseases (e.g., type 2 dia-
betes) or obesity. Indeed, to our knowledge, there has not been a prospective longitudinal study of  RE-T 
across age, i.e., contrasting responses of  younger, middle-aged, and older healthy individuals.
To address this gap, we recruited 48 men and women who formed three groups, representing young, 
middle-aged, and older ages. All individuals were physiologically and metabolically phenotyped during an 
acute study day at baseline and following 5 months of  fully supervised and progressive whole-body (WB) 
RE-T (Figure 1). At screening, we ensured each age group was well-matched in terms of  lean mass and free 
of  overt disease to preclude any influence of  sarcopenia or conditions that may interfere with responses to 
RE-T as a function of  age (e.g., there exists a negative association between insulin resistance and muscle 
mass, ref. 22).
Results
Lean mass and hypertrophic responses to RE-T
Despite no age-related differences in WB lean mass, leg lean mass, or relative skeletal mass index (RSMI: 
lean mass [kg]/height [m]) among the age groups (Table 1), or with age upon correlation analysis (Figure 2, 
A and B) before RE-T, hypertrophic responses to RE-T were blunted with advancing age. When comparing 
among the age groups, only young individuals demonstrated significant WB hypertrophy in response to 
RE-T (49,921 ± 3,065 g vs. 52,591 ± 3,347 g, P < 0.0001), with significantly greater gains in WB lean mass 
(5.24% ± 1.21%) than both middle-aged (1.12% ± 0.70%) and older (1.33% ± 0.55%) individuals (both P 
< 0.01) (Figure 2C). Assessing the relationship between advancing age and WB hypertrophic responses, 
there was a significant negative correlation between advancing age and ensuing WB hypertrophic respons-
es (R2 = 0.16, P < 0.01) (Figure 2D). Similarly, when assessing RE-T–induced changes in RSMI, there 
was a significant negative correlation between advancing age and RE-T–induced changes in RSMI (R2 = 
0.12, P < 0.05) (Figure 2F), with only young individuals demonstrating a significant increase in RSMI in 
response to RE-T (28.09 ± 1.43 vs. 29.39 ± 1.66, P < 0.01). The increase in RSMI in young individuals was 
significantly greater than that achieved by older individuals (4.43% ± 1.69% vs. 1.06% ± 0.57%, P < 0.05) 
(Figure 2E). When assessing leg hypertrophic responses, again only the young individuals demonstrated 
a hypertrophic response to RE-T (8,780 ± 533 g vs. 9,154 ± 525 g, P < 0.05) (Table 1). However, due to 
heightened heterogeneity in leg hypertrophic responses (95% CI, leg: –4.70%–8.94%; WB: –2.68%–6.93%), 
there was no correlation between advancing age and leg hypertrophic responses to RE-T. Considering sex 
Figure 1. Acute study schematic. 1-RM, 1-repetition maximum.
3insight.jci.org   https://doi.org/10.1172/jci.insight.95581
C L I N I C A L  M E D I C I N E
differences, there was no significant relationship between advancing age and WB lean mass (Figure 2A) or 
RSMI (Figure 2B) for either men or women before RE-T.
Physical function and alterations with RE-T
Similar to the data for WB lean mass, there were no significant age-related differences in WB strength 
before RE-T (despite a trend [P = 0.08] for the young to be significantly stronger than the old) (Table 1). 
This was also true for upper body strength (Table 1). The young group did, however, have significantly 
greater lower body strength than the older age group before RE-T (2,706 ± 184 vs. 1,991 ± 107 N, P < 0.05) 
(Table 1). Mirroring the results for lower body muscle strength, lower limb muscle quality was significantly 
lower in the older age group compared with the younger group before RE-T (0.31 ± 0.02 N/g vs. 0.25 ± 
0.01 N/g, P < 0.01) (Table 1). Upon correlation analysis, a significant negative relationship was observed 
between advancing age and all three facets of  strength (WB [R2 = 0.14, P < 0.01], upper body [R2 = 0.09, P 
< 0.05, and lower body [R2 = 0.17, P < 0.01]) before RE-T (Figure 3A). This was also apparent for muscle 
quality (R2 = 0.19, P < 0.01) (Figure 3B). There were, however, no significant differences in WB (Figure 
3C), upper body, or lower body strength gains made among the age groups (all P < 0.0001), with the young 
group being significantly stronger than the older group (whole [6,293 ± 405 N vs. 4,832 ± 294 N, P < 0.05] 
and lower [3,744 ± 185 N vs. 2,764 ± 179 N, P < 0.01] body) after RE-T (Table 1). There was no significant 
correlation between advancing age and any facet of  strength improvement (Figure 3D). Changes in muscle 
quality were similar to those of  strength, with no significant differences in muscle quality gains among the 
age groups (all P < 0.0001) (Figure 3E) and no significant relationship between advancing age and changes 
in muscle quality (Figure 3F).
Body composition and alterations with RE-T
WB adiposity. There were no significant differences in WB fat mass among the age groups before RE-T 
(Table 1), despite a trend for increasing WB adiposity with advancing age (R2 = 0.07, P = 0.06) (Figure 
4A). Reductions in WB adiposity with RE-T were apparent for the young (–11.4% ± 3.7%, P < 0.01) and 
Table 1. Subject physiological characteristics before and after 20-week whole-body fully supervised resistance exercise training
Mean ± SEM Young (n = 11) Middle-aged (n = 20) Older (n = 17)
Before RE-T After RE-T Before RE-T After RE-T Before RE-T After RE-T
Age (yr) 25 ± 4 50 ± 4A 70 ± 3A,B
BMI (kg/m2) 24.0 ± 0.7 23.9 ± 0.6 26.7 ± 0.7 26.6 ± 0.7 26.9 ± 0.5 26.8 ± 0.5
RSMI (kg/m) 28.1 ± 1.4 29.4 ± 1.7C 29.4 ± 1.1 29.8 ± 1.1 29.0 ± 1.2 29.3 ± 1.2
Whole body lean mass (g) 49,912 ± 3,065 52,591 ± 3,347C 50,078 ± 2,363 50,515 ± 2,277 49,192 ± 2,855 49,761 ± 2,793
Leg (dominant) lean mass (g) 8,780 ± 533 9,154 ± 525D 8,503 ± 444 8,633 ± 445 8,247 ± 547 8536 ± 572
Whole body strength (N) 4,655.3 ± 375.0 6,293.1 ± 404.7C 4,232.1 ± 312.7 5,676.8 ± 390.5C 3,505.4 ± 198.1 4,832.3 ± 294.2C,D
Upper body strength (N) 1,949.6 ± 212.7 2,579.9 ± 255.0C 1,818.9 ± 147.4 2,385.8 ± 173.3C 1,522.7 ± 112.9 2,123.2± 146.7C
Lower body strength (N) 2,705.7 ± 184.3 3,744.3 ± 185.2C 2,413.2 ± 173.1 3,191.9 ± 204.4C 1,990.0 ± 107.4 2,763.7± 179.2C,E
Muscle quality (N/g lean mass) 0.31 ± 0.02 0.41 ± 0.02C 0.28 ± 0.01 0.37 ± 0.01C,F 0.25± 0.01E 0.33± 0.01A,C
Whole-body fat (%) 26.8 ± 3.8 24.6 ± 4.1G 31.4 ± 1.7 29.9 ± 1.7G 32.0 ± 1.8 31.3 ± 1.8
Abdominal fat (%) 32.5 ± 4.2 30.4 ± 4.5D 37.2 ± 1.9 35.1 ± 2.2C 37.2 ± 2.1 36.9 ± 2.1
BMD (g/cm2) 1.28 ± 0.02 1.28 ± 0.02 1.27 ± 0.03 1.27 ± 0.03 1.21 ± 0.03 1.20 ± 0.03
MAP (mmHg) 100.2 ± 2.6 100.7 ± 2.2 113.2 ± 2.8H 106.9 ± 2.8D 117.7 ± 3.6A 114.5 ± 2.5E
LVC (l/min/100 mmHg) 0.62 ± 0.07 0.68 ± 0.07 0.43 ± 0.05H 0.50 ± 0.04H 0.36 ± 0.03A 0.47 ± 0.04H
Fasting glucose (mmol/l) 5.2 ± 0.2 5.1 ± 0.2 5.6 ± 0.2 5.5 ± 0.1 5.9 ± 0.1H 5.3 ± 0.2G
Fasting insulin (μU/ml) 4.4 ± 0.6 4.7 ± 0.2 4.4 ± 0.5 3.6 ± 0.4 5.1 ± 0.6 4.7 ± 0.4
HOMA-IR 1.01 ± 0.12F 1.09 ± 0.08 1.13 ± 0.17F 0.88 ± 0.11 1.70 ± 0.28 1.11 ± 0.12D
HDL cholesterol (mmol/l) 1.21 ± 0.09 1.18 ± 0.11 1.29 ± 0.05 1.26 ± 0.05 1.25 ± 0.06 1.32 ± 0.07
LDL cholesterol (mmol/l) 2.40 ± 0.48 2.75 ± 0.46 3.16 ± 0.23 3.03 ± 0.21 3.25 ± 0.14 3.23 ± 0.12
Triglycerides (mmol/l) 0.88 ± 0.07 0.79 ± 0.09 1.20 ± 0.12 1.16 ± 0.12 1.15 ± 0.09 1.15 ± 0.05
AP < 0.001; EP < 0.01; HP < 0.05 vs. young; BP < 0.001 vs. middle-aged; FP < 0.05 vs. older; CP < 0.001; DP < 0.05; GP < 0.01; vs. before RE-T. RSMI, 
relative skeletal mass index; BMD, bone mineral density; MAP, mean arterial pressure; LVC, leg vascular conductance; HOMA-IR, homeostasis model 
assessment of insulin resistance; RE-T, resistance exercise training.
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middle-aged (–5.0% ± 1.3%, P < 0.01) groups only (Table 1), with significantly greater losses in the young 
group when compared with the older age group (–11.4% ± 3.7% vs. –2.37% ± 0.79%, P < 0.01). Advancing 
age was associated with reduced WB RE-T–induced adipose losses (R2 = 0.21, P < 0.001) (Figure 4B). 
However, despite this age-related attenuation of  body fat losses with RE-T, there still existed no significant 
differences in WB adiposity among the age groups after RE-T (Table 1). There was, however, a significant 
relationship between advancing age and WB adiposity after RE-T (R2 = 0.10, P < 0.05) (Figure 4A).
Abdominal adiposity. Similar to the data for WB adiposity, there were no significant differences in 
abdominal (Ab) fat mass among the age groups before RE-T (Table 1), with no significant relationship 
between Ab adiposity and advancing age (Figure 4C). Only the young (–8.6% ± 2.5%, P < 0.05) and mid-
dle-aged (–6.7% ± 2.4%, P < 0.001) groups demonstrated significant reductions in Ab fat mass with RE-T 
(Table 1), with advancing age associated with reduced RE-T–induced Ab adipose losses (R2 = 0.14, P < 
0.01) (Figure 4D). However, as with WB adiposity, despite an age-related attenuation of  body fat losses 
with RE-T, there still existed no significant differences in Ab adiposity among the age groups after RE-T 
(Table 1). There was, however, a trend toward a significant relationship between advancing age and Ab 
adiposity after RE-T (R2 = 0.80, P = 0.06) (Figure 4C).
Figure 2. The effects of age 
and 20-week whole-body 
fully supervised resis-
tance exercise training on 
lean mass. Whole body 
lean mass (A) and relative 
skeletal mass index (B) 
with advancing age before 
resistance exercise training 
(RE-T). Percentage change 
in whole body lean mass in 
young, middle-aged, and 
older individuals (C) and 
with advancing age (D) in 
response to RE-T. Per-
centage change in relative 
skeletal mass index in 
young, middle-aged, and 
older individuals (E) and 
with advancing age (F) in 
response to RE-T. Data for 
C and E are shown as mean 
± SEM with individual data 
points. n = 11 young, 20 
middle-aged, and 17 older 
individuals. Within and 
between group analysis via 
2-way ANOVA with Tukey’s 
post-hoc analysis. Relation-
ship analysis via Pearson’s 
correlation. ^^^P < 0.01; 
^^^^P < 0.001 before RE-T 
vs. after RE-T; *P < 0.05; 
**P < 0.01 vs. young.
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BMD. Despite there being no significant differences in BMD among the age groups before or after 
RE-T (Table 1), there was a significant negative correlation between advancing age and BMD both before 
(R2 = 0.12, P < 0.05) and after RE-T (R2 = 0.14, P < 0.01) (Figure 4E). None of  the groups showed RE-T–
induced changes in BMD, with no difference in change among the age groups (Table 1) and no relationship 
between age and RE-T–induced changes in BMD (Figure 4F).
WB health indices and alterations with RE-T
Cardiovascular parameters. Systolic BP (SBP), diastolic BP (DBP), and mean arterial (blood) pressure 
(MAP) were significantly greater in older individuals compared with young individuals before RE-T (SBP: 
139 ± 4 mmHg vs. 118 ± 3 mmHg; DBP: 79 ± 3 mmHg vs. 68 ± 2 mmHg; MAP: 118 ± 4 mmHg vs. 100 ± 
3 mmHg, all P < 0.01) (Table 1; MAP only). All three BP parameters were also significantly greater in the 
middle-aged group (SBP: 132 ± 4 mmHg, P < 0.05; DBP: 79 ± 2 mmHg, P < 0.01; MAP: 113 ± 3 mmHg, 
Figure 3. The effects of age 
and 20-week whole-body 
fully supervised resistance 
exercise training on physical 
function and muscle quality. 
Whole body and upper and 
lower body strength (A) and 
muscle quality (leg strength in 
newtons [N] per unit lean leg 
mass [g]) (B) with advancing 
age before resistance exercise 
training (RE-T). Percentage 
change in strength (whole 
body) in young, middle-aged, 
and older individuals (C) and 
with advancing age (whole 
body, upper body, and lower 
body) (D) in response to 
RE-T (B). Percentage change 
in (leg) muscle quality in 
young, middle-aged, and 
older individuals (E) and with 
advancing age (F) in response 
to RE-T. Data for C and E are 
shown as mean ± SEM with 
individual data points. n = 11 
young, 20 middle-aged, and 17 
older individuals. Within and 
between group analysis via 
2-way ANOVA with Tukey’s 
post-hoc analysis. Relation-
ship analysis via Pearson’s 
correlation. ^^^^P < 0.001 
before RE-T vs. after RE-T.
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P < 0.05) compared with the young group (Table 1; MAP only). For all three BP parameters, there was 
a significant relationship between advancing age and BP before RE-T (SBP: R2 = 0.17, DBP: R2 = 0.15, 
MAP: R2 = 0.20, all P < 0.01) (Figure 5A; MAP only). No significant changes in SBP were observed in 
any age group following RE-T, with significant reductions in DBP (79 ± 2 mmHg vs. 73 ± 2 mmHg, P < 
0.05) and MAP (113 ± 3 mmHg vs. 107 ± 3 mmHg, P < 0.05) in the middle-aged group only (Table 1; 
MAP only). There were no significant relationships between advancing age and RE-T–induced changes in 
any of  the BP parameters (Figure 5B; MAP only). After RE-T, SBP (135 ± 3 mmHg vs. 118 ± 3 mmHg, P 
< 0.05) and MAP (115 ± 2 mmHg vs. 101 ± 2 mmHg, P < 0.01) remained greater in the older age group 
compared with the young age group, with no significant differences in DBP among the age groups (Table 
1; MAP only). The correlation between advancing age and BP parameters remained after RE-T (SBP: R2 
= 0.18, DBP: R2 = 0.11, MAP: R2 = 0.20, all P < 0.01) (Figure 5A; MAP only).
Leg vascular conductance (LVC) was significantly greater in young individuals compared with mid-
dle-aged (0.62 ± 0.07 l/min·100 mmHg vs. 0.43 ± 0.05 l/min·100 mmHg, P < 0.05) and older (0.36 ± 0.03 
l/min·100 mmHg, P < 0.001) individuals before RE-T (Table 1), with a significant negative relationship 
between age and LVC (R2 = 0.20, P < 0.01; Figure 5C). None of  the age groups demonstrated significant 
improvements in LVC in response to RE-T (Table 1), with the negative relationship between age and LVC 
remaining after RE-T (R2 = 0.18, P < 0.01) (Figure 5C). There was no relationship between advancing age and 
RE-T–induced changes in LVC (Figure 5D). After RE-T, the young age group (0.68 ± 0.07 l/min·100 mmHg) 
Figure 4. The effects of age and 
20-week whole-body fully super-
vised resistance exercise training 
on body composition parameters. 
Whole body (A) and abdominal (C) fat 
mass and bone mineral density (E) 
with advancing age before and after 
resistance exercise training (RE-T). 
Percentage change in whole body (B) 
and abdominal (D) fat mass and bone 
mineral density (F) with advanc-
ing age in response to RE-T. n = 48 
individuals. Relationship analysis via 
Pearson’s correlation.
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still displayed significantly greater LVC than both the middle-aged (0.50 ± 0.04 l·min–1·100mmHg–1) and older 
(0.47 ± 0.04 l/min·100 mmHg) age groups (both P < 0.05) (Table 1).
Fasting cholesterol and triglycerides. There were no significant differences in total cholesterol, LDL choles-
terol, or HDL cholesterol among the age groups either before or after RE-T. No significant RE-T–induced 
changes were seen in any of  these parameters, with no significant differences in changes among the age 
groups (Table 1). There were no significant relationships between age and total cholesterol or HDL choles-
terol either before or after RE-T, although a significant relationship between advancing age and LDL was 
observed before RE-T only (R2 = 0.08, P < 0.05). Levels of  plasma triglycerides were not significantly different 
among the age groups before RE-T (Table 1). Despite no significant changes in triglycerides in any age group, 
and no significant differences in changes among the age groups, a significant relationship between age and 
triglycerides was apparent after RE-T only (R2 = 0.08, P < 0.05).
Fasting insulin and glucose. There were no significant differences in fasting insulin values among the age 
groups either before or after RE-T (Table 1). Similarly, at neither time point did fasting insulin correlate 
with age. None of  the age groups demonstrated a significant reduction in fasting insulin after RE-T (Table 
1), with no relationship between changes in fasting insulin with RE-T and age.
Before RE-T, fasting glucose was significantly higher in the older age group compared with the young 
age group (5.85 ± 0.11 mmol/l vs. 5.17 ± 0.16 mmol/l, P < 0.05) (Table 1), despite no significant cor-
relation between fasting glucose and advancing age. Only the older age group demonstrated a significant 
Figure 5. The effects of age 
and 20-week whole-body 
fully supervised resistance 
exercise training on parameters 
of whole-body health. Mean 
arterial blood pressure (A), leg 
vascular conductance (C), and 
homeostasis model assessment 
of insulin resistance (HOMA-IR) 
(E) with advancing age before 
and after resistance exercise 
training (RE-T). Percentage 
change in mean arterial blood 
pressure (B), leg vascular con-
ductance (D), and HOMA-IR (F) 
with advancing age in response 
to RE-T. n = 48 individuals. Rela-
tionship analysis via Pearson’s 
correlation.
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reduction in fasting glucose with RE-T (5.85 ± 0.11 mmol/l vs. 5.33 ± 0.21 mmol/l, P < 0.01), abolishing 
the significant difference in fasting glucose between young and older subjects that was seen before RE-T 
(Table 1). There was no relationship between age and RE-T–induced changes in fasting glucose.
Employing the homeostasis model assessment (HOMA) as an index of  insulin resistance (IR), older 
individuals had significantly greater HOMA-IR (1.70 ± 0.28) than young (1.01 ± 0.12) and middle-aged 
(1.13 ± 0.17, both P < 0.05) individuals before RE-T (Table 1), with a trend for a correlation between 
advancing age and HOMA-IR (R2 = 0.08, P = 0.06) (Figure 5E). Only older individuals showed a signif-
icant reduction in HOMA-IR after RE-T (1.70 ± 0.28 vs. 1.11 ± 0.12, P < 0.05), such that the trend for a 
relationship between advancing age and HOMA-IR was not apparent after RE-T (R2 = 0.0001; P = 0.94) 
(Figure 5E). There were no significant differences in HOMA-IR among the age groups after RE-T (Table 
1). There was a trend for a relationship between advancing age and reductions in HOMA-IR (R2 = 0.06; P = 
0.09) (Figure 5F), with a highly significant correlation between HOMA-IR before RE-T and RE-T–induced 
reductions in HOMA-IR (R2 = 0.34; P < 0.0001), irrespective of  age.
MPS and RE-T
Basal fractional synthetic rate (FSR) was not significantly different among the age groups either before or after 
RE-T (Table 2), with no correlation between age and basal FSR at either time (Figure 6, A and B). Basal FSR 
was not altered in any of the age groups in response to RE-T (Table 2), with no relationship between advancing 
age and changes in basal FSR (R2 = 0.03; P = 0.24).
Similar to the results observed for basal FSR, FSR in response to acute exercise plus feeding (FedEx) 
was not significantly different among the age groups before or after RE-T (Table 2), with no correlation 
between age and FedEx FSR at either time (Figure 6, A and B). Only young individuals showed a signifi-
cantly higher FedEx FSR after RE-T compared with that before (0.08 ± 0.01 % per h vs. 0.11 ± 0.01 % per 
h, P < 0.05) (Table 2), with no significant relationship between advancing age and RE-T–induced changes 
in FedEx FSR (R2 = 0.04; P = 0.15).
The increase in FSR in response to FedEx (FedEx FSR minus basal FSR) was not significantly different 
among the age groups before or after RE-T (Table 2), with no correlation between FSR response and age 
at either time (before RE-T: R2 = 0.002, P = 0.78; after RE-T: R2 = 0.004, P = 0.68). None of  the groups 
showed changes in FSR response after RE-T compared with before (Table 2), and there was no relationship 
between age and RE-T–induced changes in FSR response to FedEx (R2 = 0.04; P = 0.16).
Relationships between baseline status and ensuing hypertrophic responses
As previously outlined, WB hypertrophic responses to RE-T were significantly blunted with advancing 
age (Figure 2D). These hypertrophic responses were not, however, associated with any aspect of  baseline 
physical function (WB, upper body, or lower body strength) or muscle quality (Table 1). In addition, despite 
younger individuals performing greater absolute work (106 ± 6.9 kg) than both middle-aged (94.3 ± 6.1 
kg) and older (86.0 ± 6.1) individuals during RE-T, there was no significant correlation between work and 
hypertrophy (R2 = 0.009; P = 0.52).
Baseline characteristics relating to body composition included WB and leg lean mass, RSMI, 
WB and Ab adiposity, the android/gynoid ratio, and BMD. As with aspects of  muscle function, 
none of  these parameters were associated with hypertrophic responses to RE-T (Table 1). Inter-
estingly, there was a significant relationship between WB adipose losses and (WB) hypertrophic 
responses (R2 = 1.36; P < 0.01).
Table 2. Fractional synthetic rates of muscle protein synthesis before and after 20-week whole-body fully supervised resistance 
exercise training
Young (n = 11) Middle-aged (n = 20) Older (n = 17)
Mean ± SEM Before RE-T After RE-T Before RE-T After RE-T Before RE-T After RE-T
Rested/fasted (basal) (%/h) 0.044 ± 0.004 0.053 ± 0.006 0.042 ± 0.003 0.048 ± 0.003 0.042 ± 0.003 0.045 ± 0.006
Feeding + exercise (%/h) 0.081 ± 0.008 0.105 ± 0.011A 0.082 ± 0.004 0.087 ± 0.006 0.083 ± 0.006 0.090 ± 0.009
AP < 0.05 vs. before RE-T. RE-T, resistance exercise training.
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Assessed cardiovascular parameters included three indices of  BP (SBP, DBP, and MAP), resting 
heart rate (RHR), leg blood flow (LBF), LVC, and leg vascular resistance (LVR). Contrary to function-
al and body composition parameters where no relationships with ensuing hypertrophy were observed, 
all three facets of  BP were significantly correlated (negatively) with WB hypertrophy. Similarly, both 
LVC and LVR were also correlated with hypertrophic responses. Cholesterol/lipid profiles, RHR, and 
LBF were not associated with hypertrophic responses (Table 1).
Fasting insulin, glucose, and HOMA-IR before RE-T were not correlated with hypertrophic responses 
to RE-T (Table 1).
There was no correlation between RE-T–induced hypertrophic responses and basal FSR values 
before or after RE-T (Tables 1 and 2). Similarly, hypertrophic responses were not correlated with 
FedEx FSR values before or after RE-T (Tables 1 and 2). In addition, hypertrophic responses to RE-T 
were not associated with FSR responses to FedEx either before (Figure 6C) or after (Figure 6D). In 
support of  this finding, hypertrophic responses were not associated with the phosphorylation of  the 
anabolic proteins P70S6K (Figure 6E) or 4EBP1 (Figure 6F) in response to FedEx, either before or 
after RE-T.
Figure 6. Relationships 
between baseline character-
istics and resistance exercise 
training–induced hypertro-
phic responses after 20-week 
whole-body fully supervised 
resistance exercise training. 
Basal (fasted and rested) 
fractional synthetic rate 
(FSR) and FSR in response to 
feeding plus acute exercise 
(FedEx; 6 × 8 leg extensions) 
with advancing age before 
(A) and after (B) resistance 
exercise training (RE-T). The 
relationship between FSR 
response to FedEx and RE-T–
induced muscle hypertrophy 
before (C) and after RE-T (D). 
The relationship between 
anabolic signaling responses 
(P70S6K [E]; 4EBP1 [F]) to 
FedEx and RE-T–induced mus-
cle hypertrophy before and 
after RE-T. n = 48 individuals. 
Relationship analysis via 
Pearson’s correlation.
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Discussion
RE-T remains a cornerstone intervention in relation to exercise for health. Herein, we conducted a sizeable 
longitudinal, highly controlled RE-T intervention study in three cohorts of  younger, middle-aged, and old-
er individuals. Our aim was to determine links between ageing physiology and metabolism in the context of  
responses to RE-T. In doing so, we highlight the global effects of  RE-T as a function of  age.
Skeletal muscle mass and function incipiently decline with ageing, albeit in a highly heterogeneous 
fashion (28). In the present study, we found that, despite all groups being well matched for lean mass 
(by DXA) at baseline, both middle-aged and older groups failed to demonstrably increase muscle mass 
— even after 5 months of  progressive RE-T. While this age-related failure in muscle hypertrophy has 
been shown in other studies (8, 18), our current data reveal that this occurs earlier in life than was previ-
ously known, i.e., 50–65 years. This suggests that whatever processes drive maladaptation to RE-T with 
ageing (e.g., endocrine, autocrine/paracrine, mechanotransduction deficiencies, ref. 8), they must also 
be present in midlife. Despite this lack of  muscle hypertrophy, all age groups showed the same relative 
increase in strength-related performance (1-repetition maximum [1-RM]) in response to RE-T. Indeed, 
while (cross-sectional) ageing was associated with declines in muscle “mechanical quality” (i.e., thigh 
mass in relation to 1-RM), RE-T stimulated relatively similar increases in all three age groups. Con-
sidering the lack of  muscle hypertrophy in middle and older-aged groups — which was not associated 
with reduced absolute workload, such increases in muscle performance and mechanical quality appear 
to be driven by factors other than muscle hypertrophy. These likely include neural adaptations relating 
to learning, coordination, and neural activation — which are reportedly well preserved in ageing (29). 
Our findings also highlight that age-related declines in muscle function and mechanical quality can 
occur in the absence of  overt muscle atrophy, highlighting the importance of  incorporating functional 
assessments into diagnostics of  sarcopenic muscle in ageing (30).
To seek potential explanations for any age-related differences in muscle mass gains with RE-T, we 
also quantified acute MPS before and after RE-T under conditions of  feeding in tandem to a single bout 
of  RE-T. Since the inception of  this study, we have shown that MPS responses to acute RE-T (in young-
er individuals) are unrelated to ensuing muscle hypertrophy following long-term RE-T (31). This fits 
with our present data, where we found no age-related differences at baseline or correlative relationships 
between MPS (nor in proxies of  mTORc1 signaling) and muscle growth. Interestingly, we did observe 
that the magnitude of  acute MPS in response to feeding plus acute resistance exercise was greater after 
RE-T in the younger cohort (i.e., those exhibiting hypertrophy) only compared with the middle- and 
older-aged cohort. As such, it is possible that acute MPS is a more sensitive predictor of  RE-T–induced 
hypertrophy if  measured in a period when exercise is more “accustomed.”
Increases in adiposity as a consequence of  ageing are associated with a host of  risk factors — especially 
in relation to excess Ab fat (32). As expected, both WB fat and Ab fat increased across age. Interestingly, 
RE-T reduced WB and Ab body fat in younger and middle-aged but not older adults. As this was not relat-
ed to work performed (relationship between work and WB adipose losses: R2 = 0.002; P = 0.77), reductions 
in body fat with RE-T may be associated with lean mass gains increasing resting energy expenditure (33), 
rather than the metabolic demands of  RE-T per se. On this basis, it is of  interest that we identified a nega-
tive correlation between RE-T–induced increases in WB lean mass and reductions in WB adiposity. There-
fore, despite increasing muscle function and mechanical quality, RE-T was ineffective in reducing body fat 
in our older cohort, at least in part due to the failure to increase lean mass. Thus, it is likely that alternative 
training regimens to RE-T (e.g., aerobic exercise, cross-training, summarized in ref. 34) are needed to evoke 
reductions in body fat in response to exercise in older individuals — especially given the fact that, in our 
study, higher energy intake could not explain this observation (Table 3).
BMD declines with age, a feature that is associated with increased risk of  osteoporosis and osteopenia, 
and exercise is recommended as a preventive and therapeutic strategy against aging-induced bone weak-
ness. Intriguingly, as for muscle anabolism, the osteogenic potential of  ageing bone in response to mechan-
ical loading is also limited (35). Here, we found that cross-sectional ageing was associated with reduced 
WB BMD but that RE-T did not ameliorate this, nor did RE-T enhance BMD in any age group. While 
important localized bone remodeling cannot be excluded, it would appear that our 5-month WB regimen 
was ineffectual in remodeling bone. This could be for several reasons, including the lack of  impact of  RE-T 
or duration required for bone remodeling (36). Future studies aimed at modulating BMD (in relation to 
ageing or otherwise) may consider the use of  longer durations or distinct exercise paradigms.
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One of  the major health benefits of  exercise 
relates to adaptation in the cardiovascular system, 
e.g., improving endothelial function, lowering BP. 
While aerobic exercise paradigms are well-estab-
lished modulators of  cardiovascular remodeling 
and function (37), strength training paradigms can 
also lower BP (38). In the present study, as expect-
ed, MAP increased across age (and in middle- and 
older-aged groups vs. our younger cohort). Howev-
er, in response to RE-T, only the middle-aged group 
exhibited declines in MAP, such that after RE-T 
these values were indistinguishable from the young-
er group. The lack of  an effect in the younger group 
is consistent with the notion that they were entirely 
normotensive at baseline. Although speculative, the 
lack of  modulation of  MAP in the older group may 
relate to the lack of  effect of  RE-T on adiposity, 
since adiposity and MAP are strongly linked (39, 
40). We also quantified LVC and noted an expect-
ed age-related decline (41, 42) but did not find any 
improvements across the groups. Given that these measures were made in the fasted and rested state, it is 
likely that RE-T did not overcome increased sympathetic vasoconstrictor activity associated with ageing 
(42). Nonetheless, this does not mean that endothelial function may not have improved; other techniques, 
such as flow-mediated dilatation, would be needed to assess this.
We also investigated the effect of  age and RE-T upon biomarkers of  metabolic health, including fasting 
glucose/insulin (and thus HOMA-IR), in addition to markers of  dyslipidemia, i.e., plasma LDL/HDL 
cholesterol and triglycerides. HOMA-IR tended to increase with age (due to increases in blood glucose) 
and was reduced by RE-T, suggesting that where HOMA-IR was elevated in the older group, RE-T is able 
to mitigate this rise; this is presumably due to the effects of  RE-T on glucose uptake and glycogen turnover 
(43). In this study, both LDL cholesterol and triglycerides also increased as a function of  age but were unaf-
fected by RE-T. While it has been suggested that RE-T is a viable alternative to aerobic exercise training to 
offset dyslipidemia, it is also clear that intense activity is required to elicit reductions in LDL cholesterol 
and triglyceride levels (44). Indeed, while intense aerobic exercise stimulates the clearance of  plasma LDL 
cholesterol and triglycerides, this is unlikely to be the case with RE-T, maybe explaining the lack of  effects 
in our older group.
As with all studies, we acknowledge some limitations. DXA is not the most accurate measure of  skeletal 
muscle mass in comparison to MRI or creatine stable isotope tracers and has been shown to underestimate 
hypertrophy (45), meaning that subtle age-related differences at baseline and following RE-T may have been 
missed. As is common practice for RE-T, the intensity of  our progressive RE-T program was based on base-
line values of  individuals (e.g., %1-RM). Therefore, our older individuals, despite performing the same rel-
ative work, performed less absolute work than the young and middle-aged subjects. In addition, the ability 
to truly assess voluntary strength beyond midlife has been questioned (46), and, although controversial, if  
correct our 1-RM assessments to determine the RE-T loads may have underestimated the relative workloads 
in our middle-aged and older groups. As high levels of  habitual physical activity may act as a stimulus for 
muscle remodeling, constant physical activity monitoring would have been advantageous. To try and con-
trol for this, all subjects recruited did not participate in regular moderate-high intensity aerobic exercise and 
none had participated in RE-T for the last 2 years. All subjects were asked to maintain their standard level of  
physical activity for the duration of  the study, with International Physical Activity Questionnaire scores not 
being significantly different among the age groups at initial screening. Similarly, all subjects were instructed 
to maintain their normal diet throughout the study to prevent exercise-induced changes, and our diet diaries 
revealed no major differences in macronutrient or micronutrient intake among the age groups (Table 3). To 
conclude, we provide a comprehensive data set relating to the effects of  RE-T as a function of  age, which 
offers valuable biological insight and that will help pave the way for testing and selecting the most appropriate 
exercise interventions aimed at improving physiological function and metabolic health in relation to ageing.
Table 3. Dietary intake during 20-week whole-body fully supervised resistance 
exercise training
Mean ± SEM Young (n = 11) Middle-aged (n = 20) Older (n = 17)
Energy (kcal) 1,785 ± 109 1,573 ± 84 1,904 ± 119
Carbohydrate (g) 197 ± 13 170 ± 9 201 ± 15
Fat (g) 22 ± 3 20 ± 2 26 ± 2
Protein (g) 18 ± 7 72 ± 5 92 ± 10
Carbohydrate (%) 48 ± 3 47 ± 2 45 ± 2
Fat (%) 30 ± 2 32 ± 1 33 ± 2
Protein (%) 18 ± 2 18 ± 1 20 ± 2
Leucine (mg) 2,471 ± 399 1,673 ± 236 2,175 ± 438
Potassium (mg) 2,701 ± 294 2,799 ± 177 3,274 ± 270
Calcium (mg) 740 ± 56 746 ± 55 793 ± 40
Iron (mg) 10 ± 1 11 ± 1 13 ± 1
Cholesterol (mg) 216 ± 36 209 ± 30 293 ± 42
Vitamin D (μg) 3 ± 1 3 ± 1 3 ± 0
RE-T, resistance exercise training.
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Methods
Subject characteristics. We recruited three groups of  subjects consisting of  young (n = 11, 25 ± 4 yr; BMI 24 ± 
1 kg/m2), middle-aged (n = 20, 50 ± 4 yr; BMI 27 ± 1 kg/m2), and older (n = 17, 70 ± 3 yr; BMI 27 ± 1 kg/
m2) men and women (~50:50) who were well matched for baseline lean mass (Table 1). All subjects were 
screened by means of  a medical questionnaire, physical examination, and resting ECG, with exclusions 
for overt muscle wasting (>1 SD below age norms); metabolic, respiratory, or cardiovascular disorders; or 
other signs and symptoms of  ill health. All subjects had normal blood chemistry, were normotensive (BP 
<140/90), and were not prescribed medication. All subjects performed activities of  daily living but did not 
routinely participate in moderate-to-high intensity aerobic exercise, and none had participated in RE-T in 
the last 2 years. Subjects were recruited over a 3-year period via poster advertisements in the local commu-
nity and via age-selected postal invites. All screening and acute study sessions took place at the University 
of  Nottingham Medical School at the Royal Derby Hospital Centre. Intervention delivery (RE-T) occurred 
at two sites, based on geographical preference of  the subjects: Derby College, Derby, United Kingdom, and 
the University of  Nottingham Fitness Centre, Nottingham, United Kingdom. All intervention delivery was 
supervised by a single member of  research staff.
Acute studies (before and after RE-T). Subjects were instructed to refrain from exercise for 72 hours prior to 
each study day and from alcohol and caffeine for 24 hours. Subjects fasted from 2100 hour the night before 
(water ad libitum) and reported to the laboratory at 0900 hours. Body composition was measured by dual-en-
ergy X-ray absorptiometry (DXA; Lunar Prodigy II, GE Medical Systems), with leg muscle mass measured 
on the dominant leg as the area inferior to the lowest visible point of  the coccyx and the Ab area defined as 
the lowest visible point of  the coccyx upward to the highest visible point of  the pelvic girdle. All other regions 
were automatically assigned by the integrated DXA software package (enCORE software, GE Healthcare).
Subjects then had a polyethylene catheter inserted into the antecubital vein of  one arm for tracer infu-
sion and the femoral vein of  one leg for venous blood sampling. A baseline blood sample was initially 
taken from the antecubital vein for measures of  fasting insulin, glucose, cholesterol, and triglycerides. Plas-
ma insulin concentrations were measured in duplicate using undiluted samples, from blood collected in 
EDTA-coated collection tubes, on a high-sensitivity human insulin ELISA (DRG Instruments GmbH). 
Plasma glucose levels were measured in duplicate using undiluted samples, from blood collected in lithium 
heparin-coated collection tubes, on a blood glucose analyzer (ILAB 300 Plus Clinical Chemistry System). 
Reports of  serum cholesterol and triglyceride profiles were produced by the Clinical Chemistry Depart-
ment at the Royal Derby Hospital by analysis of  undiluted serum samples from blood collected in serum 
separator tubes. Cholesterol profile results reported total triglycerides, total cholesterol, LDL cholester-
ol, and HDL cholesterol. Thereafter, blood samples were taken from the femoral vein every 20 minutes 
throughout the study.
After 70 minutes lying supine, measures of  RHR, SBP, and DBP were made using an OMRON 
(OMRON Healthcare UK Ltd) automated BP monitor (recorded as the mean of  3 measurements). MAP, 
calculated as two-thirds DBP plus one-third SBP, was also recorded and used to calculate LVC and LVR. 
LVC (shown as l/min•100 mmHg–1) = [LBF (l/min)/MAP (mmHg) × 100]. LVR (shown as l/min•100 
mmHg–1) = MAP (mmHg)/cardiac output (l/min)/LBF (l/min), where stroke volume was assumed to be 
70 ml irrespective of  age (47). At this time, basal LBF (femoral artery) measures were made intermittently 
for 40 minutes. A mean value from 3 measurements was used to obtain the reported basal value, with no 
significant differences between the 3 measurements made in any subject. LBF was measured using Dop-
pler ultrasound (Toshiba Nemio-17, Toshiba Medical Systems), with a single 5-MHz frequency probe to 
measure mean blood velocity (MBV) and arterial lumen diameter in the common femoral artery. Mea-
surements were made 2 to 3 cm proximal to the bifurcation of  the femoral artery to minimize the effect of  
turbulence; the insonation angle was <60°. Arterial lumen diameter (mm) was measured by video calipers 
for each measurement and was defined as the maximum distance between the media-adventitia interface 
of  the near wall and the lumen-intima interface of  the far wall of  the vessel. LBF (l/min) was calculated as 
follows: (MBV [cm/s] × π × [femoral artery radius {mm2}])/1,000 × 60.
A primed, continuous infusion (0.66 mg/kg, 1 mg/kg/h) of  [1, 2-13C2] leucine (99 atoms percentage 
excess; Cambridge Isotopes Ltd.) was started at 0 hours and maintained for the duration of  the study, with 
an increase (to 1.2 mg/kg/h) when nutrition was first provided (at 130 minutes) to prevent dilution of  
tracer. Muscle biopsies of  m. vastus lateralis were taken under sterile conditions at 0, 120, and 250 minutes 
using the conchotome biopsy technique (48), with 1% lidocaine (B. Braun Melsungen) as local anesthetic. 
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Muscle was rapidly dissected free of  fat and connective tissue, washed in ice-cold saline, and snap frozen 
in liquid N2 before storage at –80°C until further analysis.
After the second biopsy at 120 minutes, subjects performed 6 × 8 repetitions of  full-cycle leg extensions 
at 75% 1-RM on a free-standing machine (ISO Leg Extension, Leisure Lines GB Ltd.). Immediately after 
exercise (at ~130 min), the subjects received, over 2 hours, an oral feed (Fortisip, Nutricia Clinical Care), 
which supplied energy at 4.25 times basal metabolic rate, as calculated by standard equations (17). The 
feed had a composition similar to that of  a normal mixed meal (16% protein, 49% carbohydrate, and 35% 
fat) and was given as a priming bolus (3 doses immediately after exercise), with 4 further doses every 30 
minutes thereafter. Doses were between 61 and 96 ml, based upon subject body weight to provide 6.5 kJ/kg 
body weight/30 minutes. This protocol was repeated at least 3, but less than 7, days after the subjects last 
training bout at the end of  the supervised 20-week WB RE-T regime (Figure 1). This allowed us to study 
the effects of  RE-T rather than any lingering remaining acute effects of  a single exercise RE-T session (49).
During the tenth week of RE-T subjects were asked to maintain a 4-day diet diary (adapted from the Royal 
Derby Hospital dietetic department) of all food and drink consumed, with 2 of the 4 days to be days on which 
a RE-T session occurred. Diet diaries were analyzed using Microdiet version 5 (Downlee Systems Ltd.).
RE-T. The fully supervised RE-T program was designed to achieve skeletal muscle hypertrophy and 
improvements in strength, based on previously published recommendations for exercise intensity and dura-
tion (50). Subjects trained 3 times per week, with each session lasting approximately 60 minutes. During 
4 weeks of  induction training (to ensure adoption of  and adherence to correct technique) intensity was 
increased from 40% to 60% 1-RM. For the remaining 16 weeks of  training, intensity was set at 70% 1-RM, 
with multiple sets of  12 repetitions and 2 minutes of  rest between sets. The same number of  repetitions 
were performed each session over a total of  8 exercises; seated chest press, latissimus pull down, seated 
lever row, leg extension, leg curl, leg press, back extension, and Ab curl. 1-RM assessments were made 
every 4 weeks to ensure the intensity of  training remained constant, i.e., 70% 1-RM, to account for strength 
improvements. Subjects were to be excluded from the study for noncompliance, which was defined as fol-
lows: nonattendance for >6 consecutive sessions, less than 75% attendance, or failure to complete the set 
exercise regime on >15% attendance; although no subject was excluded. WB strength was determined as 
the sum of  force produced by three lower body exercises, leg extension, leg curl, and leg press, and three 
upper body exercises, latissimus pull down, lever seated row, and seated chest press, with Newtons calcu-
lated as weight lifted × 9.807 based on a standard gravitational field. Upper and lower body strength was 
determined by the sum of  force produced by the three exercises relative to that body region. Muscle quality 
was determined as lower body strength per gram lean leg mass.
MPS. Approximately 20 of  muscle tissue from each biopsy was used for measures of  MPS, as previ-
ously described (51). In brief, the myofibrillar pellet was precipitated by homogenization and centrifuga-
tion with the soluble myofibrillar protein and then precipitated by perchloric acid. Protein-bound aa were 
released by acid hydrolysis in Dowex H+ resin (Sigma-Aldrich) slurry before being purified by ion exchange 
chromatography on Dowex H+ resin. The aa were then derivatized as their N-acetyl-N-propyl esters as 
previously described (52). Incorporation of  [1,2-13C2] leucine into protein was determined by gas chroma-
tography–combustion-isotope ratio mass spectrometry (Delta Plus XP, Thermofisher Scientific) using our 
standard techniques (53), with the FSR of  myofibrillar protein determined from the incorporation of  [1, 
2-13C2], using the precursor labeling of  venous α-KIC between subsequent muscle biopsies (54). Plasma 
phenylalanine concentrations were measured via our standard techniques using a 2H2 phenylalanine inter-
nal standard, with reference to a standard curve of  known concentration (55).
Immunoblotting. To investigate the possible effects of age and/or RE-T on anabolic signaling, we measured 
protein phosphorylation of mechanistic target of rapamycin (mTORc1) substrates 4EBP1 and P70S6K1 (as 
likely indicators of such activity) in response to acute exercise plus feeding. The supernatant (sarcoplasmic 
fraction) obtained from the myofibrillar preparation described above was standardized to a protein concen-
tration of 1 mg/ml by dilution with Laemmli buffer, mixed, and heated at 95°C for 5 minutes, before 15 μg 
of protein/lane was loaded on to Criterion XT Bis-Tris 12% SDS-PAGE gels (Bio-Rad) for electrophoresis at 
200 V for 60 minutes. Proteins were electroblotted on to 0.2 μm PVDF membranes (Bio-Rad) at 100 V for 30 
minutes, and membranes were blocked in 5% low-fat milk in TBS-T (Tris-buffered saline and 0.1% Tween-20; 
both Sigma-Aldrich) for 1 hour; membranes were rotated overnight with primary antibody (Cell Signaling 
Technology) at 1:2,000 at 4°C. Membranes were washed (3 × 5 min) with TBS-T and incubated for 60 minutes 
at room temperature with HRP-conjugated anti-rabbit secondary antibody (Cell Signaling Technology), before 
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further washing (3 × 5 min) with TBS-T and incubation for 5 minutes with ECL reagents (Enhanced chemi-
luminescence kit; Immunstar; Bio-Rad). Blots were imaged and quantified by peak density within the linear 
range using the Chemidoc XRS system (Bio-Rad). Coomassie staining was used to correct for loading (56).
Statistics. Statistical analyses were performed using Graph Pad Prism version 6.00. All data are reported as 
mean ± SEM, with significance set at P < 0.05. Two-tailed Student’s t tests and 2-way rANOVA with Tukey 
post-hoc analysis were used to compare before and after training values and differences among the age groups, 
respectively. One-way ANOVA with Tukey post-hoc analysis was used to compare of responses to RE-T among 
the age groups. Pearson’s correlation was used to explore relationships between physiological parameters (i.e., 
adiposity) and/or responses to RE-T (i.e., hypertrophy).
Study approval. This study was reviewed and approved by the University of  Nottingham Medical School 
Ethics Committee (D/2/2006) and complied with the Declaration of  Helsinki. All subjects gave written 
informed consent to participate in the study prior to inclusion after all procedures and risks were explained.
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